Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

ABSTRACT: High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

PROVIDER: PRJNA176139 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (aCGH)

Project description:Prostate cancer discovery and translational research are hampered by a lack of preclinical models which accurately reproduce the biological heterogeneity observed in patients. Accordingly, we have established a bank of transplantable patient-derived prostate tumor xenograft lines, using subrenal capsule grafting of human tumor tissue into immuno-deficient mice. This panel includes the first lines generated from primary prostate cancer tissue, and also new lines from metastatic tissue. Critically, the lines retained salient features of the original patient tumors, including histopathology, clinical marker expression, chromosomal aberration and gene expression profiles. Furthermore, they span major histopathological and molecular subtypes of prostate cancer, capturing diverse inter- and intra-tumoral heterogeneity. Host castration led to the development of castrate-resistant tumors, including the first model of complete neuroendocrine transdifferentiation. This publicly-available resource provides novel tools to advance mechanistic understanding of disease progression and response to therapy, and delivers clinically-relevant model systems for evaluation of preclinical drug efficacy. 3 primary tumors and 21 xenograft tumors

2013-01-12 | E-GEOD-41188 | biostudies-arrayexpress

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (expression)

2013-01-12 | E-GEOD-41192 | biostudies-arrayexpress

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-01-12 | E-GEOD-41193 | biostudies-arrayexpress

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development

Project description:This SuperSeries is composed of the SubSeries listed below.

2013-01-12 | GSE41193 | GEO

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (expression)

Project description:Prostate cancer research is hampered by a lack of preclinical models which accurately reproduce clinical heterogeneity. We have established a bank of transplantable patient-derived prostate tumor xenograft lines, using subrenal capsule grafting of human tumor tissue into immuno-deficient mice. This panel includes the first lines generated from prostate cancer biopsy tissue, and also new lines from metastatic tissue. The lines retained salient features of the original patient tumors, including histopathological and molecular characteristics. Furthermore, they span major subtypes of prostate cancer, capturing diverse inter- and intra-tumoral heterogeneity. Host castration led to the development of castrate-resistant tumors, including the first model of neuroendocrine transdifferentiation. This publicly-available resource provides novel tools for the next-generation of prostate cancer research and therapy development.

2013-01-12 | GSE41192 | GEO

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (aCGH)

2013-01-12 | GSE41188 | GEO

Homo sapiens

Project description:High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (expression)

| PRJNA176141 | ENA

Homo sapiens

Project description:High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development (aCGH)

| PRJNA176140 | ENA

Accelerating early anti-TB drug discovery by creating mycobacterial indicator strains that predict mode of action

Project description:Accelerating early anti-TB drug discovery by creating mycobacterial indicator strains that predict mode of action

| PRJNA421834 | ENA